Human urine specimens that were determined to be presumptively positive for oxycodone and its metabolite, oxymorphone, by immunoassay screening were assayed using fast gas chromatography-mass spectrometry to positively identify and quantify the oxycodone and oxymorphone present. Urine specimens were first spiked with deuterated internal standards, oxycodone-d3 and oxymorphone-d3, subjected to acid hydrolysis, and then extracted using a positive-pressure manifold and mixedbed solid-phase cartridge extraction methodology. Extracts were derivatized using methoxylamine and acetic anhydride. The acetylated-oxime derivatives of oxycodone and oxymorphone were identified and quantified using a selective ion monitoring (SIM). The method was found to be linear for both analytes to 1600 ng/mL, and limits of detection for oxycodone and oxymorphone were found to be 40 ng/mL and 20 ng/mL, respectively. Interlahoratory data comparisons (n = 40) showed correlation coefficients of 0.9999 and 0.9997 for oxycodone and oxymorphone, respectively. Twelve semisynthetic, structurally similar compounds at concentrations of 5000 ng/mL were assayed in the presence of oxycodone and oxymorphone and found not to interfere with identification and quantitation by this method. Finally, exact mass and tandem mass spectrometry techniques were employed to elucidate the structures of the SIM ions.
Introduction
Oxycodone and oxymorphone are classified as Schedule II in the Controlled Substances Act (1) . Schedule II substances are approved for use in medical treatment in the United States In 2005, the Department of Defense (DoD) added oxycodone and oxymorphone to the panel of illicit drugs for which service members are tested. This change has necessitated the development of a cost-effective method for identifying and quantifying these drugs. The authors propose that an ideal detection method of for these analytes would: 1. contain a hydrolysis step to break the drug-glucuronide bond; 2. form stable derivatives of both the hydroxyl groups and ketone moieties that are easily resolved on methylsilicone columns; 3. form derivatives which fragment into unique, easily identifiable ions; and 4. have gas chromatographic (GC) conditions such that each derivative elutes separately. These conditions must be met in a timely manner to allow for rapid result reporting.
A review of the literature revealed that no method meeting these aforementioned requirements has been reported. Many extraction schemes utilize enzymatic means to break the drugglucuronide bond; however, this is a time-intensive step (16) . Chen et al. (17) reported that of the pentafluoropropionic anhydride, heptafluorobutyric anhydride, trifluroroacetamide, and acetic anhydride derivatives of codeine and morphine, the simple acetic anhydride derivative was the most stable (although this study did not include a hydrolysis step). Others report the use of acetic anhydride in the derivatization step, but these methods require a time-intensive liquid-liquid extraction and employ the use of the toxic solvents such as chloroform and pyridine (18, 19) . Nowatzke et al. (20) reported using a GC-mass spectrometry (MS) method capable of resolving eight common opiates; however, this method also required the use of pyridine and had exceptionally long analysis times (20 min per sample) limiting its usefulness.
Here we present a novel method for the extraction and derivatization of urinary oxycodone and oxymorphone that yields precise and reproducible GC-MS results. The hydrolysis step was performed using an autoclave and the derivatization used reagents that are inexpensive and common (methoxylamine and acetic anhydride). An interference study was completed to demonstrate that common opiates would not interfere with the identification and quantitation of oxycodone and oxymorphone or their deuterated internal standards. Finally, exact and tandem mass spectra were obtained for these derivatives (Figure 2 ) to positively identify the fragments monitored in the method. 
Materials and Methods

Chemicals and reagents
All analytical controls were prepared in-house using drugfree urine certified to be free of oxycodone and oxymorphone (Roche Diagnostics, Indianapolis, IN). Controls containing equal amounts of oxycodone and oxymorphone (Cerilliant, Round Rock, TX), included a 40 ng/mL threshold, a 100 ng/mL calibrator and a 125 ng/mL open positive control. An internal standard containing 2000 ng/mL each oxycodone-d3 and oxycodone-d3 (Cerilliant) was used as the basis for quantification, and a negative control consisting of drug-free urine and a hydrolysis control containing 100 ng/mL each morphine-d3 and morphine-6@D-glucuronide were also used. The interference study materials, including drugs of abuse, drug metabolites, and prescription pharmaceuticals, were obtained from Cerilliant, Alltech (Deerfield, IL), and the Office of the Armed Forces Medical Examiner (Armed Forces Institute of Pathology, Rockville, MD). Distilled water was obtained from a MP-6A Mega-Pure System distillation apparatus from Barnstead (Dubuque, IA). All hydrolysis and extraction reagents were obtained from Fisher Chemical (Fairlawn, NJ). The derivatization reagents methoxylamine and acetic anhydride were obtained from Aldrich (Milwaukee, WI) and Alltech, respectively. Nitrogen and helium gas (99.9% and 99.999% pure, respectively) was supplied by Airgas (Radnor, PA). Aliquots of human urine from patients on a pain management regimen were obtained without any identifying information from Ameritox Limited (Midland, TX).
Simultaneous glucuronide hydrolysis and transformation of opiold ketones to oximes
All controls and experimental samples were pipetted (2.0 mL) into 50-mL conical polypropylene centrifuge tubes. Then, 100 pL of internal standard, 0.25 mL of concentrated HCI, and 0.25 mL of methoxylamine (10%, v/v in H20) were added. The samples were then autoclaved for 30 min at a temperature of 121~ at 15 PSI to hydrolyze drug-bound glucuronides into free oxycodone and oxymorphone to promote the formation of oximes from the ketone groups of oxycodone and oxymorphone. Samples were next treated with 0.25 mL of 45% KOH in a saturated (2.0M) KHCO~ solution. Finally, the samples were mixed and centrifuged for 5 rain at 2000 rpm.
Extraction
Samples were subjected to extraction by pouring each aliquot into a separate 50 mg Cerex Polycrom TM CLIN I150-mg cation exchange resin cartridge (SPEware, San Pedro CA). The cartridges were then loaded onto a Speedisk 48 Pressure Processor (SPEware) operating between 2 and 25 psi (nitrogen gas). Following sample loading, the cartridges were subjected to serial washings with 2.0 mL water, 2.0 mL 0.1M sodium acetate buffer (pH 4.5), 1.0 mL methanol, and 1.0 mL ethyl acetate. The cartridges were then allowed to dry for 3 min under 25 psi N~. The samples were eluted from the cartridges into 15-mL glass centrifuge tubes with 3.0 mL of 1:50 (v/v) concentrated ammonium hydroxide/ethyl acetate. Finally, samples were evaporated to dryness under a stream of nitrogen gas.
Derivatization
Analyte and internal standard derivatization was achieved by adding 50 pL of acetonitrile and 50 pL of acetic anhydride to the dried extracts. The extracts were then incubated for 30 min at 60-70~ and dried under a stream of nitrogen gas at 48-50~ Finally, the samples were reconstituted with 60 IlL of ethyl acetate and transferred to automated liquid sampler (ALS) vials for fast gas chromatographic (FGC)-MS analysis.
Low-resolution GC-MS analysis
All controls and experimental samples were analyzed using an Agilent (Palo Alto, CA) 6890N GC equipped with a 7683 autosampler, a DB-5ms bonded phase capillary GC column (15 m x 0.249-mm i.d., 0.25-1am film thickness), and a 5973N mass selective detector. The GC employed a 220 V oven heater. The analytical method utilized helium (99.999%) as the carrier gas and was run with a 12:1 split-flow and performed in selected ion monitoring (SIM) mode using the ions listed in Time (rain) Figure 3 . Typical total ion chromatogram (TIC) for oxycodone and oxymorphone. The smaller peaks are impurities due to keto-enol tautomerism and incomplete derivatization. Table I . The ions chosen for SIM were selected by the Armed Forces Institute of Pathology. The Target DB software package version 4.11 (Thermo Electron Corp, Waltham, MA) was used for all data reduction and report generation. The GC oven temperature was set so that the analyte and internal standard derivatives eluted off the GC column between 1.55 and 1.75 rain. The typical temperature profile was an initial temperature of 240~ followed by a ramp of 40~ to a final temperature of 280~ which was held for 1.2 rain. The injector temperature was set at 270-280~ and the transfer line 40  41  2005  11  41  42  2006  3  46  44  2006  4  42  44  2006  3  46  43  2006  4  43  44  2006  3  46  44  2006  4  43  45  2006  3  46  44  2006  4  43  45  2006  3  47  43  2006  4  44  44  2006  1  96  91  2006  2  51  56  2006  1  97  92  2006  2  52  57  2006  1  98  91  2006  2  52  58  2006  1  98  90  2006  2  52  56  2006  1  99  92  2006  2  52  57  2005 10  100  98  2005  12  101  100  2005 10  101  98  2005  12  102  100  2005 10  101  100  2005  12  102  97  2005 10  102  98  2005  12  102  100  2005 10  103  98  2005  12  103  100  2006  7  101  100  2006  3  103  90  2006  7  103  100  2006  3  102  93  2006  7  104  97  2006  3  102  92  2006  7  105  98  2006  3  102  92  2006  7  106  99  2006  3  105  91  2006  4  280  284  2005  10  106  100  2006  4  283  283  2005  10  106  101  2006  4  283  273  2005  10  106  101  2006  4  286  283  2005  10  107  100  2006  4  287  273  2005  10  108  100  2006  2  374  393 temperature was set 5-10~ above the final oven temperature. The head pressure was set between 2 and 8 psi and the electronic pressure control was set at 1.0 mL/min. The electron multiplier was set between 0 and 600 V over autotune, and the dwell time was set at 15 ms per SIM ion to cover approximately 20 scans of each SIM ion group across each analyte peak. All sample injections were made between volumes of 0.5 and 2.0 IJL.
Exact mass and tandem MS
Exact mass and tandem mass spectra were obtained from dissolving 50-1Jg samples of the acetylated oxycodone and oxymorphone oximes dissolved in 50 pL of methanol. These samples were loaded via direct injection into a VG ZAB-T 4-sector tandem MS (Vacuum Generator, Manchester, England) for both exact mass and mass spectrum-mass spectrum (MS-MS) analysis. These analyses were performed by the Washington University Laboratory for Biomedical and Bio-Organic Mass Spectrometry (St. Louis, MO).
Results and Discussion
The acylated oxime derivatives of oxycodone and oxymor- phone were baseline resolved at retention times of approximately 1.55 and 1.75 rain, respectively (Figure 3) . Notably, the GC must be equipped with a 220 V oven to achieve the fast temperature ramp of 40~ Peak symmetries for the derivatives of oxycodone and oxymorphone and the internal standards were calculated automatically by the TargetDB software package. The software package calculates the Gaussian peak symmetry (Wb/W a) by setting a vertical line at the peak apex and then dividing the peak trailing edge distance at 10% peak height (Wb) by the peak leading edge distance at 10% peak height (Wa). Acceptance criteria required a value no greater than 2.0 (indicating tailing) and no less than 0.5 (indicating fronting). A review of 10 production batches showed the mean peak symmetries for the calibrator control were 1.097 (SD = 0.313) and 1.092 (SD = 0.195) for oxycodone and oxymorphone, respectively.
The limit of detection (LOD) and limit of quantification (LOQ) for the method were determined by analyzing (in quadruplicate) three concentrations of equal amounts of oxycodone and oxymorphone in certified negative urine (0 ng/mL, 10 ng/mL, 20 ng/mL, and 40 ng/mL, each). The LOD was defined as the lowest concentration at which the four replicate Figure 6 . Chromatogram of SIM ion m/z 372 (oxymorphone). Sample containing 5000 nglml, hydrocodone and 40 ng/mL each of oxycodone and oxymorphone (FGC-MS) method (A); sample containing 5000 nglmL hydrocodone and 40 ng/mL each of oxycodone and oxymorphone ("slow" GC-MS method)(B).
samples produced qualifier ion ratios within 20% of those set by the calibrator. The LOQ was defined as the lowest concentration at which the four replicate samples met the definition for the LOD and quantified within 10% of the expected concentration. The upper limit of linearity (ULOL) for this method was also determined by analyzing (in quadruplicate) four concentrations of oxycodone and oxymorphone in certified negative urine (200 ng/mL, 400 ng/mL, 800 ng/mL, and 1600 ng/mL each). The ULOL was defined as being the highest concentration at which the four replicate samples produced qualifier ions ratios within 20% of those set by the calibrator and all quantitated within 15% of the expected result. Additionally, the coefficient of variation of the replicates must not exceed 10%. The LOD for oxycodone and oxymorphone were determined to be 40 ng/mL and 20 ng/mL, respectively. The LOQ and ULOL for both analytes were determined to be 40 ng/mL and 1600 ng/mL, respectively.
The performance of the developed FGC-MS method was compared using 8 months of open proficiency samples (n = 40) sent to our laboratory by the Division of Forensic Toxicology, Armed Forces Institute of Pathology (AFIP). The AFIP uses a GC-MS procedure with a slower, traditional oven temperature profile to 1131A confirm for the presence of oxycodone and 1131B oxymorphone The method used by AFIP is otherwise very similar to that of NDSL-GL. It 1131C also utilizes acetic anhydride as the derivati-1131D zation agent and monitors the same SIM ions. The hydrolysis and transformation of the ketone to oxime are accomplished with the same 1136A reagents, although in different steps. Because 1136B this method has a lower temperature ramp, it results in much longer retention times for the analyte derivatives. The data from both labo-1136C ratories are tabulated in Table II and summarized in Figures 4 and 5 . The data yielded 1136D correlation coefficients for oxycodone (over a range of concentration from 40 to 975 ng/mL) equal to 0.999 and for oxymorphone (over a 1215A range of 40 to 955 ng/mL) equal to 0.999. 1215B The slope of a least-squares regression analysis is a second measure of how well the NDSL-GL generated data correlates to that generated 1215c at the AFIE The AFIP results are plotted as the t2J 50 independent variable (x-axis), and the NDSL-GL generated results are plotted as the dependent variable (y-axis) (Figures 4 and 5) . The 1235A slopes for the linear regression analysis equals 1235B 0.972 and 0.843 for oxycodone and oxymorphone, respectively. The slope for oxymorphone improves to 0.950 when the last set of data 1235c points are excluded. The difference between 1235D the results of NDSL-GL and AFIP are likely the results of a plateauing effect caused by the relatively high concentration of these samples (877 to 1047 ng/mL) as they approach the limit of linearity for this instrument at NDSL-GL.
The specificity of this analytical method with respect to interfering substances was verified using the compounds listed in Table III . Potential analytical interferences were assessed by spiking oxycodone and oxymorphone solutions (containing 40 ng/mL or 100 ng/mL of both analytes) with 5000 ng/mL of the compounds listed in Table III . Although the SIM ions for oxycodone show no interferences from these compounds at the evaluated concentrations, an interference affecting the rn/z 372 ion elutes only 0.05 rain after the oxymorphone derivative and results in unacceptable chromatography (Figure 6 ).
Except for hydrocodone, none of the compounds interfered with the analysis of oxycodone, oxymorphone, or their deuterated internal standards. Given the structure of hydrocodone, an ion with a m/z 372 is not obvious under these derivatization conditions.
The sole interfering peak, shown in Figure 6A , can be sepa- * Specimens were assayed in duplicate at two different dilutions. The %CV did not exceed more than 1.7% for any of the replicates, Extracts were processed under both "fast" and "slow" GC conditions.
rated from the rn/z 372 peak if the "fast" GC conditions are changed to a more lengthy temperature profile (220~ for 8.00 min followed by a 40~ ramp to a final temperature of 280~ Under these conditions, the oxycodone derivative will elute at approximately 6.85 rain, and the oxymorphone derivative will elute at 8.65 rain; all ions are therefore separated from this interference which elutes at 8.75 rain ( Figure 6B ). As most potential specimens would not contain this interference at m/z 372, the bulk would be processed under the "fast" method with the rapid temperature ramp to conserve instrument time, the "slow" method could be reserved as a means to separate peaks in the occasion of an interference.
To determine if hydrocodone would interfere with actual patient specimens, the authors tested the urine of four patients who were on a pain management regimen. These specimens had previously tested positive for oxycodone, oxymorphone, and hydrocodone (Table IV ). Each specimen was tested at two different dilution factors and processed under both the "fast" and "slow" GC conditions. The m/z 372 oxymorphone ion showed no interferences or chromatographic issues. The results from the "fast" and "slow" GC profiles were uniform. Given these results, the authors conclude that there are very likely to be no interferences between hydrocodone and the m/z 372 peak of oxymorphone in actual patient specimens.
The results from the exact mass studies are summarized in Table V . The experimentally and theoretically determined exact masses are in excellent agreement. Thus, the determination of the exact mass yields the molecular formula for each SIM ion. This data, along with general fragmentation chemistry principles, allows us to determine the structures of the SIM ions.
The oxycodone and oxymorphone derivatives have one key structural difference. Whereas the oxycodone derivative contains only one acetyl group [attached to the aliphatic carbon C (14) ], the oxymorphone derivative contains two acetyl groups [one attached to the C(14) and a second attached to the aromatic ring carbon C(3)] (Figure 2 ). This structural difference between these two compounds leads to the observed difference in the mass spectrum as related to the loss of an acetyl group. The rn/z 343 (oxycodone) and m/z 372 ions (oxymorphone) demonstrate losses of 43 Da and 42 Da, respectively. The m/z 372 ion in the oxymorphone derivative could be the result of the loss of either the aromatic acetyl group on C(3) or the aliphatic acetyl group on C(14); however, for the oxycodone derivative, the only source for this fragment is the aliphatic acetyl group on C (14) . Thus there is a 1 Da discrepancy in the mass spectrum of these two leaving groups. It is unlikely that two nearly identical acetyl groups on two similar compounds would produce different fragmentation patterns. The authors postulate that the differences in the spectra are because the loss of 42 Da in oxymorphone relates to loss of the aromatic acetyl group C(3), whereas the loss of 43 Da in oxycodone relates to the loss of the aliphatic acetyl group C (14) . The difference of IDa can only be the result of the aliphatic acetyl group C (14) in oxycodone leaving as an intact C(=O)CH 3 moiety, whereas the aromatic acetyl group on oxymorphone C(3) leaves the an C(=O)CH2 moiety. Evidence for this mechanism is found when acetic anhydride-d3 is substituted as the derivatization agent. In these spectra, the MS clearly shows that the aromatic acetyl group [C(3), oxymorphone] fragments as C(=O)CD2, and the aliphatic acetyl group [C (14) , oxycodone] fragments as C(=O)CD3. This is indicated by the m/z 343 ion [loss of C(=O)CD3] in oxycodone-d3 and the m/z 376 ion [loss of C(=O)CD2; deuterium transfer] in the hexa-deuterated oxymorphone derivative.
We propose that the observed differences in the fragmentation of the two different types of acetyl groups is due to the C(3) aromatic acetyl group's close proximity to the ether in the opiate backbone [i.e., the oxygen located between C(4) and C (5)]. This proximity allows the oxymorphone derivative to transfer a hydrogen from the methyl terminus of the acetyl group to the etheric oxygen via a concerted 7-member ring intermediate ( Figure 7) . In concert, the hydrogen would transfer to the ether oxygen and the oxygen-carbonyl bond in the acetyl group would break. This type of hydrogen shift is similar to a mechansim reported by McLafferty and Ture~.ek (21) . This oxymorphone scheme contrasts to that of oxycodone where the aliphatic acetyl group cleanly breaks at the carbon-carbon [C-C(=O)] bond.
A simple, semi-empirical molecular mechanical (MM2) model of the oxymorphone derivative demonstrates that a rotation about two of the acetyl group's free rotating bonds will bring the hydrogen in close proximity (0.852 ,~) to the etheric oxygen (calculated using analysis functions contained within Chem3D, CambridgeSoft Corporation, Cambridge, MA). This is far closer than is typical for O-H bond lengths, such as in ethanol (0.971 A) (22) and is certainly close enough for facile hydrogen transfer to the oxygen atom. It is this difference in structure that may result in the observed difference in the mass spectra. 
Conclusions
The detection of oxycodone and oxymorphone by the developed method meets each of our self-imposed criteria. This method utilized an acid-catalyzed, autoclave-facilitated hydrolysis step to break the drug-glucuronide bond. Derivatives of both the hydroxyl and ketone groups were generated with acetic anhydride and methoxylamine treatment. The FGC-MS method allowed for the resolution of oxycodone and oxymorphone from 12 other common potential opiate interferants. The total run time for a sample is typically less than 3 rain, less than half that of the previous "slow" method at NDSL-GL and approximately a quarter of the run time required per sample at AFIP.
